Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia

Published:2016-09-09 Issue:10 Volume:5 Page:e1226720
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

McWilliams Emily M.¹²,Mele Jennifer M.²,Cheney Carolyn²,Timmerman Elizabeth A.²,Fiazuddin Faraz²,Strattan Ethan J.²,Mo Xiaokui³,Byrd John C.²,Muthusamy Natarajan²,Awan Farrukh T.²

Affiliation:

1. Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, USA

2. Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA

3. Center for Biostatistics, The Ohio State University, Columbus, OH, USA

Funder

Lymphoma Research Foundation

National Cancer Institute

The D. Warren Brown Foundation

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1226720

Reference32 articles.